IFF reported FY 2025 net sales of USD 10.9 billion (-5%), with gross profit of USD 3.9 billion (-5%) and gross margin of 36.2%. The company posted an operating loss of USD 382 million, compared with an operating profit in the prior year, and a net loss attributable to shareholders of USD 361 million (loss per share: USD 1.41). Results included a USD 1.2 billion goodwill impairment tied to the Food Ingredients reporting unit and a USD 488 million gain on extinguishment of debt; interest expense was USD 229 million (-25%). Cash flows provided by operating activities were USD 850 million, while cash and cash equivalents ended the year at USD 590 million; total debt was USD 6.0 billion and net debt was USD 5.4 billion. By segment in FY 2025, Taste sales were USD 2.5 billion (+2%), Food Ingredients sales were USD 3.3 billion (-3%), Health & Biosciences sales were USD 2.3 billion (+4%), and Scent sales were USD 2.5 billion (+2%). Pharma Solutions sales were USD 369 million (-65%) following the divestiture of the Pharma Solutions disposal group on May 1, 2025 and the nitrocellulose business on May 9, 2025. IFF also said it expects FY 2026 capital spending to be approximately 6% of sales and noted it paid FY 2025 dividends of USD 409 million (USD 1.60 per share).

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IFF - International Flavors & Fragrances Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000051253-26-000006), on February 27, 2026, and is solely responsible for the information contained therein.